The groundbreaking approach of the medication represents a exciting advance in the management of type 2 diabetes. Unlike existing drugs, tirzepatide targets dual pathways – GLP-1 and GIP – providing greater sugar https://tirzepatidepeptide502992.bloggerchest.com/42151562/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment